Metabolic Dashboard
Metabolic hiddenness becomes clearer when sponsor class, phase structure, and stock are separated
The metabolic dashboard isolates family-specific sponsor mix, phase mix, and leading sponsors rather than folding them into an all-registry average.
Sponsor classes
Phases
Top sponsors
Family-specific stock
Dashboard
Metabolic hiddenness is driven by a mix of broad academic stock and substantial industry backlog rather than a single sponsor type.
How to read the dashboard
Eligible older
17,294
Metabolic studies
No-results rate
76.2%
2-year no-results
Largest phase bucket
9,811
nan
Top sponsor stock
391
Novo Nordisk A/S
Sponsor-class rates
OTHER_GOV remains near the top where present, but the broader metabolic burden is still shaped by the much larger OTHER and INDUSTRY blocks.
This is a family-specific rate view, so it should be read alongside the top-sponsor stock chart rather than as a standalone leaderboard.
Phase pattern
EARLY_PHASE1 is the quietest major phase inside the metabolic family on the no-results metric.
Phase structure matters because the family-level average can hide very different early-phase and late-phase behavior.
Largest sponsor stocks
Novo Nordisk A/S carries the largest named missing-results stock in this family at 391 studies.
The top-sponsor chart makes the family-specific backlog concrete instead of leaving it as a single family-wide percentage.
Read Across Projects
Across The Series
Each project isolates a different dimension of registry opacity, but the point is the contrast between them, not a single leaderboard.
Industry
CT.gov Industry Disclosure Gap
Industry-focused missing-results stock, sponsor backlogs, and structural sparsity inside CT.gov.
Sponsor Classes
CT.gov Sponsor-Class Hiddenness
Sponsor-class comparisons on rate, stock, and structural hiddenness rather than one flattened ranking.
Phases
CT.gov Phase Reporting Gap
Phase-by-phase disclosure gaps showing how silence changes along the development pathway.
Structural
CT.gov Structural Missingness
Field-level missingness across publication links, IPD statements, descriptions, and locations.
Visibility
CT.gov Evidence Visibility Gap
Results-plus-publication visibility states showing how many older trials are fully visible, partly visible, or ghosted.
Cohorts
CT.gov Completion Cohort Debt
Completion-era reporting debt showing how older eligible cohorts drift on no-results and ghost-protocol rates.
Conditions
CT.gov Condition Hiddenness Map
Keyword-classified therapeutic-area hiddenness mapping across common condition families.
Concentration
CT.gov Sponsor Backlog Concentration
Concentration and inequality analysis showing how much unresolved stock sits inside a thin sponsor slice.
Rule Eras
CT.gov Rule-Era Reporting Gap
Policy-era comparisons across pre-FDAAA, FDAAA, and later CT.gov completion cohorts.
PubMed Audit
CT.gov Publication Undercount Audit
Sample-based external PubMed NCT audit testing how often CT.gov no-link records hide an external paper trail.
Oncology
CT.gov Oncology Hiddenness
Oncology-specific CT.gov hiddenness showing where cancer-trial stock, phases, and sponsors still go quiet.
Cardiovascular
CT.gov Cardiovascular Hiddenness
Cardiovascular CT.gov hiddenness showing how heart and vascular studies remain quiet across major phases and sponsors.